StockData
Starling Oncology, Inc. logo

Starling Oncology, Inc. (STLN) stock

STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$3.40−0.14 (-3.95%)

Close on Nov 17, 2026Market cap $346.52MP/E –Yield –

Starling Oncology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Starling Oncology's market cap was $421.97M on Nov 11, 2026, against $306.37M a year earlier. Over the last 5 years it ranged from $12.24M to $660.22M, with a median of $182.30M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$421.97M+21.5%
2025Dec 31, 2025$347.35M+1387.7%
2024Dec 31, 2024$23.35M-84.5%
2023Dec 29, 2023$150.41M+26.0%
2022Dec 30, 2022$119.36M-46.8%
2021Dec 31, 2021$224.25M+261.1%
2020Dec 31, 2020$62.10M–

More Starling Oncology figures

See a number that looks wrong?